Expert consensus recommendations for the suspicion and diagnosis of transthyretin cardiac amyloidosis

MS Maurer, S Bokhari, T Damy, S Dorbala… - Circulation: Heart …, 2019 - Am Heart Assoc
Cardiomyopathy is a manifestation of transthyretin amyloidosis (ATTR), which is an
underrecognized systemic disease whereby the transthyretin protein misfolds to form fibrils …

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2—evidence base …

S Dorbala, Y Ando, S Bokhari, A Dispenzieri… - Journal of Nuclear …, 2019 - Springer
Cardiac amyloidosis is a form of restrictive infiltrative cardiomyopathy that confers significant
mortality. Due to the relative rarity of cardiac amyloidosis, clinical and diagnostic expertise in …

How to image cardiac amyloidosis: a practical approach

S Dorbala, S Cuddy, RH Falk - Cardiovascular Imaging, 2020 - jacc.org
Cardiac amyloidosis (CA) is one of the most rapidly progressive forms of heart disease, with
a median survival from diagnosis, if untreated, ranging from< 6 months for light chain …

JCS 2020 guideline on diagnosis and treatment of cardiac amyloidosis

H Kitaoka, C Izumi, Y Izumiya, T Inomata, M Ueda… - Circulation …, 2020 - jstage.jst.go.jp
[CQ1] What is the role of 99 mTc-PYP scintigraphy (bone scintigraphy) in clinical practice for
CA?∙∙∙∙∙∙ 1655 [CQ2] The role of endomyocardial biopsy. Which site is appropriate for biopsy …

[HTML][HTML] Procedural recommendations of cardiac PET/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation (4Is)-related cardiovascular …

RHJA Slart, AWJM Glaudemans, O Gheysens… - European journal of …, 2021 - Springer
With this document, we provide a standard for PET/(diagnostic) CT imaging procedures in
cardiovascular diseases that are inflammatory, infective, infiltrative, or associated with …

Diagnostic imaging of cardiac amyloidosis

A Martinez-Naharro, AJ Baksi, PN Hawkins… - Nature Reviews …, 2020 - nature.com
Systemic amyloidosis encompasses a debilitating, under-diagnosed but increasingly
recognized group of disorders characterized by the extracellular deposition of misfolded …

Myocardial amyloidosis: the exemplar interstitial disease

M Fontana, A Ćorović, P Scully, JC Moon - JACC: Cardiovascular Imaging, 2019 - jacc.org
Cardiac involvement drives prognosis and treatment choices in cardiac amyloidosis.
Echocardiography is the first-line examination for patients presenting with heart failure, and …

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2—evidence base …

S Dorbala, Y Ando, S Bokhari… - Circulation …, 2021 - Am Heart Assoc
Sharmila Dorbala, MD, MPH, FASNC, Chair*; Yukio Ando, MD, PhD†; Sabahat Bokhari,
MD‡; Angela Dispenzieri, MD § ; Rodney H. Falk, MD*; Victor A. Ferrari, MD∥; Marianna …

[18F]-florbetaben PET/CT for differential diagnosis among cardiac immunoglobulin light chain, transthyretin amyloidosis, and mimicking conditions

D Genovesi, G Vergaro, A Giorgetti, P Marzullo… - Cardiovascular …, 2021 - jacc.org
Objectives This study aimed to test the diagnostic value of [18F]–florbetaben positron
emission tomography (PET) in patients with suspicion of CA. Background Diagnosis of …

State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis

V Singh, R Falk, MF Di Carli, M Kijewski… - Journal of Nuclear …, 2019 - Elsevier
Cardiac amyloidosis, once considered untreatable, is now gaining well-deserved attention
due to advances in imaging and the recent approval of targeted breakthrough therapies. In …